Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134167) titled 'The influence of sivelestat sodium on postoperative pulmonary complications in patients undergoing elective neurosurgery' on Oct. 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second People's Hospital of Guiyang City
Condition:
Patients scheduled for neurosurgery
Intervention:
Sivritasin Sodium Group:Sivritasin sodium intravenous infusion
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-09-30
Target Sample Size: Sivritasin Sodium Group:69;control group:69;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showp...